By: Zusha Elinson, Julie Wernau
Operators promise high-end treatment, help addicts sign up for insurance then pile on charges for little in return, say former patients and insurers.


Julie Wernau is a Health and Medicine Correspondent at The Wall Street Journal. She focuses on consumer health, drugs and medication, mental health, and health news, often sharing insights from her interactions with individuals who use drugs and those who care for them. Julie's work has been featured in The Wall Street Journal, MarketWatch, El Paso Inc., LiveMint, Magzter, Yahoo Finance, MSN, and Tradeoffs.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)


Not enough data
Julie Wernau’s coverage primarily focuses on health-related issues, particularly the opioid crisis and mental health. She often cites data and government announcements, indicating a reliance on authoritative sources for her reporting.
If you have expertise in public health policy or can provide insights based on official reports or studies related to mental health, drug addiction, or the opioid crisis in the United States, your input may be valuable to Julie's work. Additionally, if you can offer perspectives that shed light on healthcare regulations or trends within these areas of focus, she may find them relevant for her articles.
Given Julie's national focus within the US, pitches should take into account this geographic scope when offering expert opinions or insights.
This information evolves through artificial intelligence and human feedback. Improve this profile .